82 related articles for article (PubMed ID: 12496196)
1. Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo.
Harth G; Horwitz MA
Infect Immun; 2003 Jan; 71(1):456-64. PubMed ID: 12496196
[TBL] [Abstract][Full Text] [Related]
2. Structure of Mycobacterium tuberculosis glutamine synthetase in complex with a transition-state mimic provides functional insights.
Krajewski WW; Jones TA; Mowbray SL
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10499-504. PubMed ID: 16027359
[TBL] [Abstract][Full Text] [Related]
3. A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
Zelmer A; Carroll P; Andreu N; Hagens K; Mahlo J; Redinger N; Robertson BD; Wiles S; Ward TH; Parish T; Ripoll J; Bancroft GJ; Schaible UE
J Antimicrob Chemother; 2012 Aug; 67(8):1948-60. PubMed ID: 22635525
[TBL] [Abstract][Full Text] [Related]
4. The role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistence.
Thayil SM; Morrison N; Schechter N; Rubin H; Karakousis PC
PLoS One; 2011; 6(11):e28076. PubMed ID: 22132215
[TBL] [Abstract][Full Text] [Related]
5. Metronidazole therapy in mice infected with tuberculosis.
Brooks JV; Furney SK; Orme IM
Antimicrob Agents Chemother; 1999 May; 43(5):1285-8. PubMed ID: 10223954
[TBL] [Abstract][Full Text] [Related]
6. Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs.
Tullius MV; Harth G; Horwitz MA
Infect Immun; 2003 Jul; 71(7):3927-36. PubMed ID: 12819079
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glutamine synthetase: a potential drug target in Mycobacterium tuberculosis.
Mowbray SL; Kathiravan MK; Pandey AA; Odell LR
Molecules; 2014 Aug; 19(9):13161-76. PubMed ID: 25162957
[TBL] [Abstract][Full Text] [Related]
8. All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis.
Harth G; Maslesa-Galić S; Tullius MV; Horwitz MA
Mol Microbiol; 2005 Nov; 58(4):1157-72. PubMed ID: 16262797
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of glutamine synthetase and their potential application in medicine.
Berlicki Ł
Mini Rev Med Chem; 2008 Aug; 8(9):869-78. PubMed ID: 18691144
[TBL] [Abstract][Full Text] [Related]
10. Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis.
Parveen S; Shen J; Lun S; Zhao L; Alt J; Koleske B; Leone RD; Rais R; Powell JD; Murphy JR; Slusher BS; Bishai WR
Nat Commun; 2023 Nov; 14(1):7427. PubMed ID: 37973991
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen metabolism in mycobacteria: the key genes and targeted antimicrobials.
Xu Y; Ma S; Huang Z; Wang L; Raza SHA; Wang Z
Front Microbiol; 2023; 14():1149041. PubMed ID: 37275154
[TBL] [Abstract][Full Text] [Related]
12. Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase in
Chanda A; Kalita S; Mishra AK; Changkakoti L; Sarma JB; Biswas K; Kakati D; Mohanta YK; Tanti B; Mahanta S; Saravanan M
Biomed Res Int; 2022; 2022():4661491. PubMed ID: 36225979
[TBL] [Abstract][Full Text] [Related]
13. Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study.
Chen X; Ye J; Lei H; Wang C
Front Cell Infect Microbiol; 2022; 12():827528. PubMed ID: 35402287
[TBL] [Abstract][Full Text] [Related]
14. Assembly status transition offers an avenue for activity modulation of a supramolecular enzyme.
Chen Y; Xu W; Yu S; Ni K; She G; Ye X; Xing Q; Zhao J; Huang C
Elife; 2021 Dec; 10():. PubMed ID: 34898426
[TBL] [Abstract][Full Text] [Related]
15. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers.
Albors-Vaquer A; Rizvi A; Matzapetakis M; Lamosa P; Coelho AV; Patel AB; Mande SC; Gaddam S; Pineda-Lucena A; Banerjee S; Puchades-Carrasco L
Emerg Microbes Infect; 2020 Dec; 9(1):1131-1139. PubMed ID: 32486916
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Glutamine Synthetase-Coding Gene
Millanao AR; Mora AY; Saavedra CP; Villagra NA; Mora GC; Hidalgo AA
Front Microbiol; 2020; 11():428. PubMed ID: 32265871
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Mycobacterium tuberculosis Exploits Multiple Host Nitrogen Sources during Growth in Human Macrophages.
Borah K; Beyß M; Theorell A; Wu H; Basu P; Mendum TA; Nӧh K; Beste DJV; McFadden J
Cell Rep; 2019 Dec; 29(11):3580-3591.e4. PubMed ID: 31825837
[TBL] [Abstract][Full Text] [Related]
18. Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of
Wang Z; Soni V; Marriner G; Kaneko T; Boshoff HIM; Barry CE; Rhee KY
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19646-19651. PubMed ID: 31501323
[TBL] [Abstract][Full Text] [Related]
19. Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic.
Nadar VS; Chen J; Dheeman DS; Galván AE; Yoshinaga-Sakurai K; Kandavelu P; Sankaran B; Kuramata M; Ishikawa S; Rosen BP; Yoshinaga M
Commun Biol; 2019; 2():131. PubMed ID: 30993215
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, In Vitro Screening and Docking Studies of New Thiosemicarbazide Derivatives as Antitubercular Agents.
Pitucha M; Karczmarzyk Z; Swatko-Ossor M; Wysocki W; Wos M; Chudzik K; Ginalska G; Fruzinski A
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
